NeuroPace (NPCE) Operating Expenses (2020 - 2026)

NeuroPace has reported Operating Expenses for 7 years, with the latest figure at $24.0 million in Q2 2026.

• On a quarterly basis, Operating Expenses fell 1.45% year-over-year to $24.0 million in Q2 2026; TTM through Jun 2026 was $93.8 million, a 8.55% increase from a year earlier, with the FY2025 full-year figure at $93.6 million, up 15.85% from the prior year.
• Operating Expenses was $24.0 million for Q2 2026 at NeuroPace, up from $23.6 million in the prior quarter.
• The five-year high for Operating Expenses was $24.4 million in Q2 2025, with the low at $18.0 million in Q1 2022.
• Average Operating Expenses over 5 years is $20.6 million, with a median of $19.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Operating Expenses soared 45.72% in 2022, then decreased 1.45% in 2026.
• Over 5 years, Operating Expenses stood at $18.7 million in 2022, then retreated by 0.35% to $18.6 million in 2023, then gained by 6.69% to $19.8 million in 2024, then gained by 12.62% to $22.3 million in 2025, then climbed by 7.63% to $24.0 million in 2026.
• The last three Operating Expenses figures came in at $24.0 million (Q2 2026), $23.6 million (Q1 2026), and $22.3 million (Q4 2025), per Business Quant data.